You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ipilimumab

Showing 876 - 900 of 914
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Melanoma With Metastasis Trial in Herlev (Vaccine consisting of a peptide derived from the protein IDO)

Completed
  • Malignant Melanoma With Metastasis
  • Vaccine consisting of a peptide derived from the protein IDO
  • Herlev, Denmark
    Department of Oncology, Herlev Hospital
Sep 25, 2014

Melanoma Trial in Puerto Rico, United States (BMS-982470 (recombinant interleukin-21), Ipilimumab)

Completed
  • Melanoma
  • BMS-982470 (recombinant interleukin-21)
  • Ipilimumab
  • Scottsdale, Arizona
  • +8 more
Aug 28, 2014

NSCLC Trial in Chuo-ku (Ipilimumab, 3 mg, Ipilimumab, 10 mg, Paclitaxel)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Ipilimumab, 3 mg
  • +3 more
  • Chuo-ku, Tokyo, Japan
    Local Institution
Jun 23, 2014

Definition ofImmune Signature Predictive of Anti-PD1 Antibody in

Unknown status
  • Malignant Melanoma
  • Biopsies
  • (no location specified)
Oct 24, 2016

Advanced Melanoma Trial in United States (Ipilimumab)

Completed
Has Results
  • Advanced Melanoma
  • Ipilimumab
  • Los Angeles, California
  • +6 more
May 20, 2014

Melanoma Trial in United States (Ipilimumab, Corticosteroid: Betamethasone, Corticosteroid: Dexamethasone)

Completed
Has Results
  • Melanoma
  • Ipilimumab
  • +9 more
  • Scottsdale, Arizona
  • +13 more
May 27, 2014

Metastatic Melanoma Trial (Anti-OX40, Ipilimumab)

Withdrawn
  • Metastatic Melanoma
  • (no location specified)
Mar 31, 2014

Lung Cancer - Non Small Cell Trial in Worldwide (Ipilimumab, Pemetrexed)

Terminated
Has Results
  • Lung Cancer - Non Small Cell
  • Ipilimumab
  • Pemetrexed
  • Greenbrae, California
  • +12 more
Apr 14, 2014

Melanoma Trial in Worldwide (Ipilimumab, Placebo, Dacarbazine)

Completed
Has Results
  • Melanoma
  • Ipilimumab
  • +2 more
  • Anaheim, California
  • +126 more
Oct 24, 2014

Childhood Solid Tumor Trial in Vienna (AV0113 DC-CIT, Data evaluation)

Completed
  • Childhood Solid Tumor
  • AV0113 DC-CIT
  • Data evaluation
  • Vienna, Austria
  • +1 more
Dec 28, 2015

Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • MART-1 antigen
  • +5 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014

Ocular Melanoma Trial in Germany (Ipilimumab)

Completed
  • Ocular Melanoma
  • Ipilimumab
  • Erlangen, Bayern, Germany
  • +24 more
Jun 20, 2014

Advanced Melanoma Trial in United States (Ipilimumab, Carboplatin, Paclitaxel)

Completed
Has Results
  • Advanced Melanoma
  • Ipilimumab
  • +3 more
  • Los Angeles, California
  • +3 more
Dec 31, 2013

Prostate Cancer, Tumor Metastasis Trial in United States (MDX-010)

Completed
Has Results
  • Prostate Cancer
  • Neoplasm Metastasis
  • Los Angeles, California
  • +13 more
Aug 14, 2014

Metastatic Melanoma Trial in San Francisco (Biochemo + bevacizumab then ipilimumab)

Completed
  • Metastatic Melanoma
  • Biochemo + bevacizumab then ipilimumab
  • San Francisco, California
    San Francisco Oncology Associates
Aug 28, 2013

Melanoma Trial in Tampa, New York (BMS-908662, Ipilimumab)

Completed
  • Melanoma
  • Tampa, Florida
  • +1 more
Jun 11, 2013

Melanoma (Skin) Trial (gp100:209-217(210M) peptide vaccine, gp100:280-288(288V) peptide vaccine, incomplete Freund's adjuvant)

Withdrawn
  • Melanoma (Skin)
  • gp100:209-217(210M) peptide vaccine
  • +3 more
  • (no location specified)
May 14, 2013

Melanoma Trial in Brazil (Ipilimumab)

No longer available
  • Melanoma
  • Ipilimumab
  • Salvador, Bahia, Brazil
  • +8 more
May 30, 2013

Melanoma Trial in Los Angeles (MDX-CTLA4 Antibody; Tyrosinase/gp100/MART-1 Peptides Melanoma Vaccine)

Completed
  • Melanoma
  • MDX-CTLA4 Antibody; Tyrosinase/gp100/MART-1 Peptides Melanoma Vaccine
  • Los Angeles, California
    Universtiy of Southern California/Kenneth Norris, Jr. Comprehens
May 20, 2014

Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (aldesleukin, ipilimumab)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • aldesleukin
  • ipilimumab
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • gp100 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Recurrent Head Neck Cancer Trial in Denver (IPI-926 and Cetuximab)

Completed
  • Recurrent Head and Neck Cancer
  • IPI-926 and Cetuximab
  • Denver, Colorado
    University of Colorado Denver
Jan 29, 2014

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +61 more
  • ipilimumab
  • therapeutic allogeneic lymphocytes
  • La Jolla, California
  • +4 more
Mar 26, 2013

Melanoma (Skin) Trial run by the CC (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)

Completed
  • Melanoma (Skin)
  • gp100 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 21, 2012

Prostate Cancer Trial in Amsterdam (GVAX and ipilimumab)

Terminated
  • Prostate Cancer
  • GVAX and ipilimumab
  • Amsterdam, Netherlands
    VU university medical center
Jan 10, 2012